Investigator, The Lundquist Institute; Professor of Psychiatry & Biobehavioral Sciences and Pediatrics, David Geffen School of Medicine at UCLA Vancouver, British Columbia–(Newsfile Corp. – June 28, 2021) – Lobe Sciences Ltd. (“ Lobe” or the “Company“) (CSE: LOBE) (OTC Pink: GTSIF) is pleased to announce the appointment of Charles Grob, MD Investigator, The Lundquist Institute…


Previous articleAwakn Life Sciences Files Patent Applications In U.S. For AWKN001 And AWKN002, Two Next- Generation New Chemical Entities [NCEs] To Treat A Broad Range Of Addiction Indications
Next articleCOMPASS Pathways completes COMP360 psilocybin therapy administration for 216 patients in large-scale phase IIb psilocybin therapy trial for treatment-resistant depression